Glecaprevir/Pibrentasvir and Renal Dysfunction in Deceased Donor Renal Transplantation: A Case Report

Kaba, A; Yamanaga, S; Hidaka, Y; Toyoda, M; Kashima, M; Takekuma, Y; Inadome, A; Yokomizo, H; Miyata, A

Kaba, A (通讯作者),Japanese Red Cross Kumamoto Hosp, Higashi Ku, 2-1-1 Nagamine Minami, Kumamoto 8618520, Japan.

TRANSPLANTATION PROCEEDINGS, 2022; 54 (2): 549

Abstract

Background. Glecaprevir/pibrentasvir is a novel anti-hepatitis C virus (HCV) drug, and it is currently the only drug available for patients with sever......

Full Text Link